(2E)-2-[[3-(3,4-difluorophenyl)-1H-pyrazol-5-yl]methylidene]-5-methoxy-6-methyl-3H-inden-1-one
C21H16F2N2O2 — CID 122414189
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2E)-2-[[3-(3,4-difluorophenyl)-1H-pyrazol-5-yl]methylidene]-5-methoxy-6-methyl-3H-inden-1-one
(2E)-2-[[3-(3,4-difluorophenyl)-1H-pyrazol-5-yl]methylidene]-5-methoxy-6-methyl-3H-inden-1-one (PubChem CID 122414189) has the molecular formula C21H16F2N2O2 and a molecular weight of 366.37 g/mol. Its IUPAC name is (2E)-2-[[3-(3,4-difluorophenyl)-1H-pyrazol-5-yl]methylidene]-5-methoxy-6-methyl-3H-inden-1-one.
Molecular Properties
| Compound Name | (2E)-2-[[3-(3,4-difluorophenyl)-1H-pyrazol-5-yl]methylidene]-5-methoxy-6-methyl-3H-inden-1-one |
|---|---|
| PubChem CID | 122414189 |
| Molecular Formula | C21H16F2N2O2 |
| Molecular Weight | 366.37 g/mol |
| Exact Mass | 366.12 |
| IUPAC Name | (2E)-2-[[3-(3,4-difluorophenyl)-1H-pyrazol-5-yl]methylidene]-5-methoxy-6-methyl-3H-inden-1-one |
| SMILES | COc1cc2c(cc1C)C(=O)/C(=C/c1cc(-c3ccc(F)c(F)c3)n[nH]1)C2 |
| InChI | InChI=1S/C21H16F2N2O2/c1-11-5-16-13(9-20(11)27-2)6-14(21(16)26)7-15-10-19(25-24-15)12-3-4-17(22)18(23)8-12/h3-5,7-10H,6H2,1-2H3,(H,24,25)/b14-7+ |
| InChIKey | MWJVQSGIDFSCRY-VGOFMYFVSA-N |
| XLogP | 4.49 |
| TPSA | 54.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 366.37 |
| LogP ≤ 5 | 4.49 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122414189 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.